Evidence map›Paper›PMID 38341809›Full record

SynthesisClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2024

Criteria and indicators to evaluate quality of care in genitourinary tumour boards.

Javier Puente, Ferrán Algaba Arrea, Óscar Buisán Rueda, Daniel Castellano Gauna, Ignacio Durán, Juan José Fernández Ávila, Alfonso Gómez-Iturriaga, Mariano José Parada Blázquez, Daniel Pérez Fentes, Gemma Sancho Pardo and 4 more

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 1 country.

Javier PuenteServicio de Oncología Médica, Hospital Universitario Clínico San Carlos, Madrid, Spain. javierpuente.hcsc@gmail.com.ORCID http://orcid.org/0000-0002-6910-1331
Ferrán Algaba ArreaServicio de Anatomía Patológica, Fundació Puigvert, Barcelona, Spain.
Óscar Buisán RuedaServicio de Urología, Hospital Universitario de Bellvitge, Barcelona, Spain.ORCID http://orcid.org/0000-0001-6368-249X
Daniel Castellano GaunaFundación ECO (Excelencia y Calidad de La Oncología), Madrid, Spain.
Ignacio DuránFundación ECO (Excelencia y Calidad de La Oncología), Madrid, Spain.
Juan José Fernández ÁvilaServicio de Farmacia Hospitalaria, Hospital Clínico Universitario Virgen de La Arrixaca, Murcia, Spain.
Alfonso Gómez-IturriagaServicio de Oncología Radioterápica, Hospital Universitario de Cruces, Instituto de Investigación Sanitaria Biobizkaia, Vizcaya, Spain.ORCID http://orcid.org/0000-0002-1094-5839
Mariano José Parada BlázquezServicio de Radiodiagnóstico, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Daniel Pérez FentesServicio de Urología, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
Gemma Sancho PardoServicio de Oncología Radioterápica, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.ORCID http://orcid.org/0000-0003-2266-6172
Juan Antonio Vallejo CasasServicio de Medicina Nuclear, Hospital Universitario Reina Sofía, IMIBIC, Córdoba, Spain.
Paula GratalFundación ECO (Excelencia y Calidad de La Oncología), Madrid, Spain.ORCID http://orcid.org/0000-0003-1622-2065
María Teresa PardoFundación ECO (Excelencia y Calidad de La Oncología), Madrid, Spain.ORCID http://orcid.org/0000-0003-0576-8425
Vicente Guillem PortaFundación ECO (Excelencia y Calidad de La Oncología), Madrid, Spain.
Bellvitge University Hospital · ESBioCruces Health research Institute · ESComplejo Hospitalario Universitario de Santiago · ESHospital Clínico San Carlos · ESHospital de Sant Pau · ESHospitales Nisa · ESHospital Universitario 12 De Octubre · ESHospital Universitario Virgen de la Arrixaca · ESHospital Universitario Virgen del Rocío · ESInstituto de Investigación Marqués de Valdecilla · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESPuigvert Foundation · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGenitourinary (GU) multidisciplinary tumour boards (GUMTBs) are key components of patient care, as they might lead to changes in treatment plan, improved survival, and increased adherence to guidelines. However, there are no guidelines on how GUMTBs should operate or how to assess their quality of performance.

methodsA systematic literature review was conducted to identify criteria and indicators to evaluate quality in GUMTBs. A scientific committee-comprising 12 GU cancer specialists from seven disciplines-proposed a list of criteria and developed indicators, evaluated in two rounds of Delphi method. Appropriateness and utility of indicators were scored using a 9-point Likert scale. Consensus was defined as at least two-thirds of Delphi respondents selecting a score sub-category that encompassed the median score of the group.

resultsForty-five criteria were selected to evaluate the quality of GUMTBs covering five dimensions: organisation, personnel, protocol and documentation, resources, and interaction with patients. Then, 33 indicators were developed and evaluated in the first round of Delphi, leading to a selection of 26 indicators in two dimensions: function, governance and resources, and GUMTB sessions. In the second round, consensus was reached on the appropriateness of all 26 indicators and on the utility of 24 of them. Index cards for criteria and indicators were developed to be used in clinical practice.

conclusionsCriteria and indicators were developed to evaluate the quality of GUMTBs, aiming to serve as a guide to improve quality of care and health outcomes in patients with GU cancer.

Indexed as

Delphi TechniqueQuality Indicators, Health CareUrogenital NeoplasmsConsensusHumansMedical OncologyPatient Care TeamQuality of Health CareDelphiGenitourinary cancerIndicatorsQuality of careSpainTumour board

Identifiers

PMID38341809
OpenAlexW4391734176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.